Install App Extra 10% Off on APP

Sabal serrulata 1x

Introduction

Botanically known as Chamaerop serrulata Michx, Serenoa serrulata. Sabal serrulata is a well-established herb for urinary troubles in elderly. Commonly known as Saw palmetto, it is found on Atlantic coast of U.S.A. from south Carolina to Florida. It contains steriodal saponins, volatile and fixed oils, polysaccharides and tannins. Its homoeopathic tincture is made from the ripe fruit. It is covered by both Homoeopathic Pharmacopoeia of India and German Homoeopathic Pharmacopoeia.1

Urinary troubles in elderly

Urinary troubles in elderly people have various causes. Though the causative factors includes, changes in the kidney and bladder, infection and subsequent (elderly people may have more chances of getting urinary tract infection), weak control system, etc., enlarged prostate problem occurs in majority of men. It troubles elderly males with symptoms like retention of urine, irritation and increased urgency and frequency of urination, nocturia, incontinence resulting from bladder irritation. In extreme unattended cases there may be complete retention of urine. 2

Sabal serrulata acts on irritability to the genito-urinary organs. It is used in general and sexual debility. It promotes nutrition and tissue building. It is of great value in prostatic enlargement, epididymitis and urinary difficulties. It also acts on membrano-prostatic portion of urethra.3,4,5 It is used in iritis, with prostatic trouble. Research on it reports that it strengthens the neck of the bladder and reduces the size of prostrate. Research on Dr. Willmar Schwabe, Germany’s Sabal serrulata special extract confirm it to be an effective in the treatment of benign prostatic hyperplasia (BPH) symptoms, along with Urtica urens extract.6,7,8 Recent studies demonstrate that it acts through the inhibition of 5alpha-reductase inhibitors and DHT-induced PSA secretion.9,10

Indications: Urinary trouble in elderly such as retention of urine, irritation and increased urgency and frequency of urination, nocturia, incontinence resulting from bladder irritation.

Complementary medicines: Sabal Pentarkan

Dosage:  Unless otherwise prescribed, 2-4 tablets 2-3 times a day. Reduce the dose as symptoms improve. If complaints are not relieved, consult a specialist.

Side effects:  No side effects of Schwabe’s Sabal serrulata 1x are known. 

Contraindications and interactions:  No contra-indications and interactions with other drugs for the use of Schwabe’s Sabal serrulata 1x are known.

Presentation:  Bottle of 20gm.

Reference:

  1. P. N. Varma, Indu Vaid, Encyclopaedia of Homoeopathic Pharmacopoeia, Updated edition 2007, B. Jain Publishers, New Delhi.
  2. Laura J. Martin, David Zieve. Aging changes in the kidneys and bladder. Medline Plus Medical Encyclopaedia, National Institutes of Health, U.S. Department of Health and Human Services. Available at: https://www.nlm.nih.gov/medlineplus/ency/article/004010.htm. Retrieved on: 19th November 2015.
  3. T. F. Allen, Encyclopaedia of Pure Materia Medica, B. Jain Publishers, New Delhi.
  4. J. H. Clarke, Dictionary of Practical Materia Medica, Reprint Edition 1992, B. Jain Publishers, New Delhi.
  5. W. Boericke, New Manual of Homoeopathic Materia Medica & Repertory [with Relationship of Remedies], Second Re-Augmented & Revised Edition Based on Ninth Edition, Reprint Edition 2002, B. Jain Publishers, New Delhi.
  6. Engelmann U, Walther C, Bondarenko B, Funk P, Schläfke S, Efficacy and Safety of a Combination of Sabal and Urtica Extract in Lower Urinary Tract Symptoms. Arzneimittelforschung (Drug Res) 2006; 56 (3): 222-229.
  7. Lopatkin N, Sivkov A, Walther C, Schläfke S, Medvedev A, Avdeichuk J, Golubev G, Melnik K, Elenberger N, Engelmann U. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms-a placebo-controlled, double-blind, multicenter trial. World J Urol. 2005; 23: 139-146.
  8. Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. Br J Urol 2000 (86):439–442.
  9. Bayne CW, Donnelly F, Ross M, Habib FK. Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor-new evidence in a coculture model of BPH. Prostate. 1999 Sep 1;40(4):232-41.
  10. Habib FK, Ross M, Ho CK, Lyons V, Chapman K. Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Int J Cancer. 2005 Mar 20;114(2):190-4.